Establishment Labs Holdings (ESTA) Has Almost Doubled Its Share Price Since Its PRISM Women’s Health Index Debut, Two Months Ago
Not only is Establishment Labs Holdings Inc. (ESTA) up 24% today, it’s also been steadily rising since the start of the year. The company who has been included in the PRISM Women’s Health Index since the indices’ inception on January 4th of this year, had traded around $25/share and is now approaching $50 with a current share price of $47.
Todays upward movement is likely attributed to its recent earnings announcement. Despite reporting a net loss, the company surpassed estimates and increased its revenue guidance. Over the past two months, Establishment Labs has announced an amended credit facility with Oaktree as well as its first US commercial procedure with its breast aesthetic and reconstructive product, the Motiva Flora® SmoothSilk® Tissue Expander. Additionally, the company has launched the product in China.
Establishment Labs Holdings is a global medical technology company that specializes in developing and commercializing innovative breast implant technologies. The company focuses on advanced breast aesthetics and reconstruction solutions, leveraging cutting-edge materials and techniques to provide safer, more natural-looking results for patients. Establishment Labs aims to revolutionize the breast implant industry through its commitment to research, development, and patient satisfaction.
Top of Form
